Taylor Morrison Home
TMHC
Meritage Homes
MTH
D.R. Horton
DHI
Lennar Corp
LEN
Toll Brothers
TOL
US Stock MarketDetailed Quotes
CMMB Chemomab Therapeutics
- 1.550
- -0.130-7.74%
Close Feb 25 16:00 ET
- 1.530
- -0.020-1.29%
Post 20:01 ET
29.23MMarket Cap-1.65P/E (TTM)
1.697High1.432Low286.54KVolume1.680Open1.680Pre Close445.94KTurnover2.42%Turnover RatioLossP/E (Static)18.86MShares2.55052wk High1.79P/B18.32MFloat Cap0.57952wk Low--Dividend TTM11.82MShs Float184.000Historical High--Div YieldTTM15.77%Amplitude0.420Historical Low1.556Avg Price1Lot Size
Chemomab Therapeutics News
Chemomab Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Chemomab Therapeutics | EFFECT: Others
Chemomab Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adi Mor(4.8%),Kobi George(4.8%)
Chemomab Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Erik Otto(6.1%)
Chemomab Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Chemomab Therapeutics | 424B5: Prospectus
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel BioFund GP Limited Partnership(9.99%),OrbiMed Israel GP Ltd.(9.99%), etc.
Chemomab Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Chemomab Therapeutics | 424B3: Prospectus
Chemomab Therapeutics | EFFECT: Others
Chemomab Therapeutics | CORRESP: CORRESP
Chemomab Therapeutics | UPLOAD: Others
Chemomab Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Chemomab Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sphera Funds Management Ltd.(6.56%),Sphera Global Healthcare GP Ltd.(6.56%), etc.
Chemomab Therapeutics | D: Filing D
Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.